For example, compared to standard temozolomide chemotherapy alone, TTFields combined with temozolomide prolonged overall survival in patients with newly diagnosed GBM, regardless of O6-methylguanine DNA methyltransferase (MGMT) promoter methylation status [2]. Here, MGMT is linked to glioblastoma.